18 related articles for article (PubMed ID: 38745849)
1. Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis.
Song WB; Soffer DE; Gelfand JM
Dermatol Clin; 2024 Jul; 42(3):417-428. PubMed ID: 38796273
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease prevention in women - the current state in 2023.
Purohit A; Kim YJ; Michos ED
Curr Opin Cardiol; 2024 Jan; 39(1):54-60. PubMed ID: 37921758
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Dynamics in HIV: The Influence of Adrenal Function and Nutritional Status.
Niwaha AJ; Byrd JB
Circ Res; 2024 May; 134(11):1566-1580. PubMed ID: 38781299
[TBL] [Abstract][Full Text] [Related]
4. The Role of Genetics on Psoriasis Susceptibility, Comorbidities, and Treatment Response.
Bui A; Orcales F; Kranyak A; Chung BY; Haran K; Smith P; Johnson C; Liao W
Dermatol Clin; 2024 Jul; 42(3):439-469. PubMed ID: 38796275
[TBL] [Abstract][Full Text] [Related]
5. TNF inhibitors and cardiovascular risk: Friend or foe?
Gelfand JM; Garshick M
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):995-996. PubMed ID: 38794923
[No Abstract] [Full Text] [Related]
6. Cardiovascular Disease and Dementia: Exploring Intersections, Risks, and Therapeutic Challenges.
Huang L; Meir J; Frishman WH; Aronow WS
Cardiol Rev; 2024 May; ():. PubMed ID: 38785445
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Health and Disease in the Pakistani American Population.
Sadaf MI; Akbar UA; Nasir K; Hanif B; Virani SS; Patel KV; Khan SU
Curr Atheroscler Rep; 2024 Jun; 26(6):205-215. PubMed ID: 38669004
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and cancer: friend or foe?
Turizo-Smith AD; Córdoba-Hernandez S; Mejía-Guarnizo LV; Monroy-Camacho PS; Rodríguez-García JA
Front Pharmacol; 2024; 15():1385479. PubMed ID: 38799159
[TBL] [Abstract][Full Text] [Related]
9. Bile Acids and Bilirubin Role in Oxidative Stress and Inflammation in Cardiovascular Diseases.
Punzo A; Silla A; Fogacci F; Perillo M; Cicero AFG; Caliceti C
Diseases; 2024 May; 12(5):. PubMed ID: 38785758
[TBL] [Abstract][Full Text] [Related]
10. Disparities in patients' understanding of cardiovascular disease management.
Ayob R; Vally M; Khan R; Orchard A
Cardiovasc J Afr; 2024 May; 34():1-7. PubMed ID: 38800882
[TBL] [Abstract][Full Text] [Related]
11. Sex specific considerations in cardiovascular drug therapy.
Rabinovich-Nikitin I; Liu S; Kirshenbaum L
Can J Physiol Pharmacol; 2024 May; ():. PubMed ID: 38781601
[TBL] [Abstract][Full Text] [Related]
12. Intercellular pathways of cancer treatment-related cardiotoxicity and their therapeutic implications: The paradigm of radiotherapy.
Logotheti S; Pavlopoulou A; Rudsari HK; Galow AM; Kafali Y; Kyrodimos E; Giotakis AI; Marquardt S; Velalopoulou A; Verginadis II; Koumenis C; Stiewe T; Zoidakis J; Balasingham I; David R; Georgakilas AG
Pharmacol Ther; 2024 May; ():108670. PubMed ID: 38823489
[TBL] [Abstract][Full Text] [Related]
13. Multi-treatment resistance to biological treatment in patients with psoriasis: Definitions and implications.
Henckens NFT; Thomas SE; van den Reek JMPA; de Jong EMGJ;
J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38818854
[No Abstract] [Full Text] [Related]
14. Correction to "The emerging role of IL-38 in diseases: A comprehensive review".
Immun Inflamm Dis; 2024 May; 12(5):e1287. PubMed ID: 38808650
[No Abstract] [Full Text] [Related]
15. Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review.
Mehta H; Narang T; Dogra S; Handa S; Hatwal J; Batta A
Vasc Health Risk Manag; 2024; 20():215-229. PubMed ID: 38745849
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
